These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29744846)

  • 21. Pathways of Amyloid-β Aggregation Depend on Oligomer Shape.
    Barz B; Liao Q; Strodel B
    J Am Chem Soc; 2018 Jan; 140(1):319-327. PubMed ID: 29235346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.
    Murray B; Sorci M; Rosenthal J; Lippens J; Isaacson D; Das P; Fabris D; Li S; Belfort G
    Proteins; 2016 Apr; 84(4):488-500. PubMed ID: 26799157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear magnetic resonance evidence for the dimer formation of beta amyloid peptide 1-42 in 1,1,1,3,3,3-hexafluoro-2-propanol.
    Shigemitsu Y; Iwaya N; Goda N; Matsuzaki M; Tenno T; Narita A; Hoshi M; Hiroaki H
    Anal Biochem; 2016 Apr; 498():59-67. PubMed ID: 26772162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico investigation and targeting of amyloid β oligomers of different size.
    Autiero I; Saviano M; Langella E
    Mol Biosyst; 2013 Aug; 9(8):2118-24. PubMed ID: 23708585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of stable amyloid β-protein oligomers of defined assembly order.
    Rosensweig C; Ono K; Murakami K; Lowenstein DK; Bitan G; Teplow DB
    Methods Mol Biol; 2012; 849():23-31. PubMed ID: 22528081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the aggregation free energy landscape of the amyloid-β protein (1-40).
    Zheng W; Tsai MY; Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11835-11840. PubMed ID: 27698130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification.
    Kotler SA; Brender JR; Vivekanandan S; Suzuki Y; Yamamoto K; Monette M; Krishnamoorthy J; Walsh P; Cauble M; Holl MM; Marsh EN; Ramamoorthy A
    Sci Rep; 2015 Jul; 5():11811. PubMed ID: 26138908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
    Murakami K
    Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and Purification of Intrinsically Disordered Aβ Peptide and Setup of Reproducible Aggregation Kinetics Experiment.
    Linse S
    Methods Mol Biol; 2020; 2141():731-754. PubMed ID: 32696387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization and Characterization of Cytotoxic Aβ
    Mannini B; Habchi J; Chia S; Ruggeri FS; Perni M; Knowles TPJ; Dobson CM; Vendruscolo M
    ACS Chem Neurosci; 2018 Dec; 9(12):2959-2971. PubMed ID: 29986583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes.
    Hayden EY; Conovaloff JL; Mason A; Bitan G; Teplow DB
    Anal Biochem; 2017 Feb; 518():78-85. PubMed ID: 27810329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
    Lopez del Amo JM; Fink U; Dasari M; Grelle G; Wanker EE; Bieschke J; Reif B
    J Mol Biol; 2012 Aug; 421(4-5):517-24. PubMed ID: 22300765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent Probe DCVJ Shows High Sensitivity for Characterization of Amyloid β-Peptide Early in the Lag Phase.
    Nagarajan S; Lapidus LJ
    Chembiochem; 2017 Nov; 18(22):2205-2211. PubMed ID: 28892583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators.
    Yi X; Feng C; Hu S; Li H; Wang J
    Analyst; 2016 Jan; 141(1):331-6. PubMed ID: 26613550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers.
    Huang D; Zimmerman MI; Martin PK; Nix AJ; Rosenberry TL; Paravastu AK
    J Mol Biol; 2015 Jul; 427(13):2319-28. PubMed ID: 25889972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy.
    Ionuţ Iuraşcu M; Cozma C; Tomczyk N; Rontree J; Desor M; Drescher M; Przybylski M
    Anal Bioanal Chem; 2009 Dec; 395(8):2509-19. PubMed ID: 19838688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
    Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
    Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous Monitoring of Amyloid-β (Aβ) Oligomers and Fibrils for Effectively Evaluating the Dynamic Process of Aβ Aggregation.
    Yu Y; Yin T; Peng Q; Kong L; Li C; Tang D; Yin X
    ACS Sens; 2019 Feb; 4(2):471-478. PubMed ID: 30693761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.